% Expired Patents = 100.0

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 47

Loading Chart...

7 inventors (with patents filed for the assignee):

R Loch Macdonald (5 out of 6 patents)

Brian A Leuthner (2 out of 2 patents)

Parissa Heshmati (1 out of 3 patents)

4. Gary Anthony Winchester (1 out of 5 patents)

5. Kevin Burton (1 out of 9 patents)

6. Cara R Davis (1 out of 2 patents)

7. Angela R Stella (1 out of 2 patents)

8. R Loch Macdonald (1 patent)

9. Brian Leuthner (0 patent)

10. Loch R Macdonald (0 patent)

5 patents: Sort by Forward Citations

1. 10092524 - Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage (2018-10-09),

2. 9399019 - Polymorph compositions, methods of making, and uses thereof (2016-07-26),

3. 9364432 - Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow (2016-06-14),

4. 8303974 - Drug delivery system for the prevention of cerebral vasospasm (2012-11-06),

5. 8252302 - Methods and compositions to treat hemorrhagic conditions of the brain (2012-08-28),

Edge Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for the treatment of life-threatening neurological conditions. The company's lead product candidate, EG-1962, is a novel therapy designed to improve outcomes for patients with aneurysmal subarachnoid hemorrhage. Edge Therapeutics is dedicated to advancing the field of neurology and improving patient care through cutting-edge research and development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#6 in New Providence, NJ

#1,896 in New Jersey

#51,545 in US

New Providence, NJ, United States of America

Edge Therapeutics, Inc.

Forward Citations = 47

7 inventors:

R Loch Macdonald (5 out of 6 patents)

Brian A Leuthner (2 out of 2 patents)

Parissa Heshmati (1 out of 3 patents)

4. Gary Anthony Winchester (1 out of 5 patents)

5. Kevin Burton (1 out of 9 patents)

Please report any incorrect information to [email protected]

2 patents (CIPO):

Please report any incorrect information to [email protected]

3 patents (EPO):

Please report any incorrect information to [email protected]